---
title: "Thomson Medical Group Limited (A50.SG)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/A50.SG.md"
symbol: "A50.SG"
name: "Thomson Medical Group Limited"
industry: "医疗机构"
---

# Thomson Medical Group Limited (A50.SG)

| Item | Detail |
|------|--------|
| Industry | 医疗机构 |
| Location | 新加坡市场 |
| Website | [www.thomsonmedical.com](https://www.thomsonmedical.com) |

## Company Profile

汤姆森医疗集团有限公司是一家投资控股公司，在新加坡、马来西亚和越南提供女性和儿童的医疗服务。该公司拥有并运营汤姆森医疗中心，以及一系列医疗诊所和设施。它还提供紧急护理服务，如基本复苏、心电图、疫苗接种、肌肉注射/静脉注射液体和静脉抗生素给药、手术和程序、伤口护理和缝合、X 光和基本实验室检测；健康筛查服务；与皮肤和美容、疼痛和康复管理相关的服务；以及草药茶。此外，该公司还提供专业服务，如女性健康、儿童健康、生育和家庭计划、眼健康、普通外科、泌尿科、预防健康和健康老龄化、诊断影像、乳腺健康、心脏病学、呼吸医学和重症护理、内分泌学、皮肤病学、日间手术、外科护理、咨询和治疗、传统中医（TCM），以及...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-15T04:30:12.000Z

**Overall: D (0.64)**

**Industry**: Health Care Facilities

| Metric | Value |
|--------|-------|
| Industry Ranking | 6 / 8 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 13.56% |  |
| Net Profit YoY | -5802.89% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 3.23 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.56B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 469.73M |  |


**Multi Score**: D

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -9.03% | D |
| Profit Margin | -9.57% | D |
| Gross Margin | 39.74% | B |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 13.56% | B |
| Net Profit YoY | -5802.89% | E |
| Total Assets YoY | -2.08% | D |
| Net Assets YoY | -4.08% | D |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -1045.22% | E |
| OCF YoY | 13.56% | B |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.26 | D |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 68.29% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Thomson Medical Group Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-9.03%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-9.57%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "39.74%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "13.56%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-5802.89%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-2.08%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-4.08%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-1045.22%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "13.56%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.26",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "68.29%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | BDMS TH SDR 1to2 (SG.TBDD) | B | B | B | B | B | B |
| 02 | IHH医疗保健 (SG.Q0F) | B | B | C | C | B | B |
| 03 | 莱佛士医疗 (SG.BSL) | B | C | C | B | B | B |
| 04 | 国际眼科中心 (SG.40T) | B | B | B | B | B | B |
| 05 | Econ Healthcare Asia (SG.EHG) | B | A | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -34.73 | 7/7 | 2352.59 | 2199.16 | 2148.02 |
| PB | 3.23 | 6/7 | 3.37 | 2.84 | 2.22 |
| PS (TTM) | 3.32 | 6/7 | 3.54 | 3.37 | 2.94 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-10T16:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 50% |
| Overweight | 0 | 0% |
| Hold | 1 | 50% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.06 |
| Highest Target | 0.07 |
| Lowest Target | 0.05 |

## References

- [Company Overview](https://longbridge.com/en/quote/A50.SG/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/A50.SG/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/A50.SG/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.